TP53 and neoplasm: After preferentially penetrating cancer cells, azurin inhibits the growth of tumor cells leading to tumor cell shrinkage and death via multiple mechanisms including (i) binding to the DNA-binding domain (DBD) of the tumor-suppressor protein p53 and (ii) anti-proliferative and (iii) pro-apoptotic activity (22).